Hartwig Medical Foundation
To make the right treatment decision, cancer specialists need to collect all the available diagnostic information from the patient and their tumor.
We are contributing to this work by:
innovative molecular tests, for identifying the characteristics of the tumor.
Collecting and storing
knowledge of and information about the patient and their tumor.
the information and knowledge with treatment outcome to accelerate scientific research. This enables us to learn from the data of today’s patients and provide better treatment for the patients of tomorrow.
Share your data and share our vision for the future of cancer diagnosis
Read the latest news
Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics
Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …
Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board
On July 14, Prince Constantijn of the Netherlands succeeded Robbert Dijkgraaf as chairman of the Supervisory Board of Hartwig Medical …
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …
In the media: Rarity – Personalised cancer treatment – fact not fiction
Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …
Novel catalog interface Hartwig Medical Database with whole genome sequenced tumor genomes
Hartwig Medical Foundation has presented a novel catalog interface of the Hartwig Medical Database with whole genome sequenced tumor genomes: https://catalog.hartwigmedicalfoundation.nl. …
Complete DNA analysis for young adults with cancer
KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …
We want to extract the maximum amount of information from the patient’s tumor. This DNA test is the The complete DNA test is the best available tool to extract the maximum amount of information from the patient’s tumor. We only need one tissue sample with sufficient tumor cells. We literally analyze the entire genome, including parts of the DNA that show mutations of which we don’t yet know the importance. This test is tumor-independent and future-proof. These are the two most important advantages of WGS.